Search

everythinglearnresearchcommunity

for

Search:↓

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

EGFR deficiency causes significant changes in skin cells and hair follicles.

EGFR helps protect hair follicles from bacterial infections.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

EGFR deficiency in skin causes hair follicle issues and inflammation.

EGF and EGFR are important for goat skin development, increasing from weeks 6 to 21.

EGF and EGFR are essential for goat fetal skin development.

EGFR inhibitors often cause dry, brittle hair and eyebrow/eyelash changes.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Erlotinib can cause nonscarring hair loss and itchy skin.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Removing EGFR in skin causes inflammation and abnormal hair growth.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Fumai Paste helps heal skin damage from chemotherapy better than magnesium sulfate.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Sesamin may help treat hair loss by affecting specific cell pathways.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

SOX4 is crucial for the development of melanoma.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.